Escalation of adjuvant endocrine therapy for early hormone-dependent HER2-negative breast cancer: to whom, when and why?

• Hoofdauteur: I. V. Kolyadina (Auteur)
• Formaat: Boek
• Gepubliceerd in: ABV-press, 2024-05-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

This review presents the evolution of adjuvant endocrine therapy for early hormone-dependent HER2-negative breast cancer, describes late relapse phenomenon, provides clinical rationale for escalation of treatment, analyzes the key stages of the metastatic cascade, and provides a scientific rationale...